1-3 of 3
Vishalkumar Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The efficacy and safety of pirtobrutinib in patients with CLL/SLL: A phase 2 dose optimization trial in progress

Free
Alexey Danilov, Alvaro Alencar, Jackson Gao, Jennifer Chen Zhao, Minna Balbas, Vishalkumar Patel, Suhyun Kang, Bruce Cheson
Journal: Blood
Blood (2025) 146 (Supplement 1): 5690.
https://doi.org/10.1182/blood-2025-5690
Published: 2025
Journal Articles

BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (IdelaR) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Free
Jeff P. Sharman, Talha Munir, Sebastian Grosicki, Lindsey Roeker, John M. Burke, Christine I Chen, Norbert Grzasko, George Follows, Zoltán Mátrai, Alessandro Sanna, Shuhua Yi, Ru Feng, Vu Minh Hua, Jadwiga Holodja, Wojciech Jurczak, Matthias Ritgen, Lu-Gui Qiu, Francesc Bosch, Catherine C. Coombs, Katherine Bao, Vishalkumar Patel, Bin Liu, Livia Compte, Ananya Guntur, Ying (Denise) Wang, Marisa Hill, Ching Ching Leow, Paolo Ghia, Paul M Barr
Journal: Blood
Blood (2024) 144 (Supplement 1): 886.
https://doi.org/10.1182/blood-2024-198147
Published: 2024
Journal Articles

A First-in-Human Phase 1 Study of Oral LOXO-338, a Selective BCL2 Inhibitor, in Patients with Advanced Hematologic Malignancies (Trial in Progress)

Free
Alvaro J. Alencar, Lindsey E. Roeker, Marc Hoffmann, Guru Subramanian Guru Murthy, Vishalkumar Patel, Nora C. Ku, James M. Pauff, Toby A. Eyre, Wojciech Jurczak, Steven Le Gouill
Journal: Blood
Blood (2021) 138 (Supplement 1): 2424.
https://doi.org/10.1182/blood-2021-145380
Published: 2021